XWPharma Names Michael M. Morrissey, PhD to Board of Directors

Appointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development Appointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development

Read the rest here:
XWPharma Names Michael M. Morrissey, PhD to Board of Directors

Related Post